An assets sale is tipped as the next move for the embattled pathology provider.
An assets sale is tipped as the next move for the embattled pathology provider.
End of content
No more pages to load
From The Source
- DoHAC: Four new Medicare Mental Health Centres for North Brisbane and Moreton Bay
- Australian Medical Council annual report
- Ramsay Health Care: Armidale Private Hospital doc celebrates 1,000 new knees
- Botanix Pharmaceuticals: First Sofdra prescriptions as commercialisation ramps up
- Botanix Pharmaceuticals: First Sofdra prescriptions as commercialisation ramps up
- DoHAC: Aged Care Transition Taskforce Summary of Meeting – 11 December 2024
- AAHMS: Academy calls for a national human biomonitoring program to track the health impacts of forever chemicals
- DoHAC: Strengthening Medicare – General Practice Grants Program Evaluation: Final Report
- Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
- Have ED times really improved enough to prevent another child’s death?
- NDIS gets $1b injection to slow growth even as budget slides into deficit
- Peter MacCallum Cancer Centre: IMCT Network Refresh